|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/4965 | (2006.01) |
| A61K 31/497 | (2006.01) | ||
| A61P 7/06 | (2006.01) |
| (11) | Number of the document | 2704721 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12722013.5 |
| Date of filing the European patent application | 2012-05-03 | |
| (97) | Date of publication of the European application | 2014-03-12 |
| (45) | Date of publication and mention of the grant of the patent | 2018-04-11 |
| (46) | Date of publication of the claims translation | 2018-07-10 |
| (86) | Number | PCT/US2012/036412 |
| Date | 2012-05-03 |
| (87) | Number | WO 2012/151451 |
| Date | 2012-11-08 |
| (30) | Number | Date | Country code |
| 201161482171 P | 2011-05-03 | US |
| (72) |
SU, Shin-San Michael, US
DANG, Lenny, US
|
| (73) |
Agios Pharmaceuticals, Inc.,
88 Sidney Street, Cambridge, MA 02139,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Piruvato kinazės aktyvatoriai, skirti panaudoti terapijoje |
| PYRUVATE KINASE ACTIVATORS FOR USE IN THERAPY |
| Payment date | Validity (years) | Amount | |
| 2025-04-22 | 14 | 289.00 EUR |
| 2026-05-03 |